Because of the threats posed by counterfeit manufacturers, branded pharmaceutical firms spend significant resources to protect their patents and intellectual property around the world. Branded pharmaceutical manufacturer have pursued legal action at the WTO and against individual nations. In 1995, the WTO’s agreement on Trade-Related Aspects of intellectual Property Right (TRIPS) was approved by approximately 150 WTO member countries.